Carlo Ballatore
Overview
Explore the profile of Carlo Ballatore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
2607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takomthong P, Waiwut P, Yenjai C, Wangboonskul J, Plekratoke K, Arsito P, et al.
PLoS One
. 2025 Mar;
20(3):e0316888.
PMID: 40063637
Alzheimer's disease (AD), a growing global challenge, lacks effective preventive and therapeutic strategies. This study explored the promising potential of the Kaempferia parviflora (KP) and its methoxyflavones (MFs) against the...
2.
Liu L, Lucero B, Manriquez-Rodriguez C, Francisco K, Teixeira T, Yohannan D, et al.
ACS Omega
. 2024 Aug;
9(32):34829-34840.
PMID: 39157084
The 20S proteasome is a multimeric protease complex that is essential for proteostasis in the cell. Small molecule proteasome inhibitors are approved drugs for various cancers and are advancing clinically...
3.
Yao Y, Muench M, Alle T, Zhang B, Lucero B, Perez-Tremble R, et al.
Alzheimers Dement
. 2024 Jun;
20(7):4540-4558.
PMID: 38884283
Introduction: Intraneuronal inclusions composed of tau protein are found in Alzheimer's disease (AD) and other tauopathies. Tau normally binds microtubules (MTs), and its disengagement from MTs and misfolding in AD...
4.
Lucero B, Francisco K, Varricchio C, Liu L, Yao Y, Brancale A, et al.
ChemMedChem
. 2024 Jan;
19(8):e202300656.
PMID: 38277231
Studies have shown that depending on the substitution pattern, microtubule (MT)-targeting 1,2,4-triazolo[1,5-a]pyrimidines (TPDs) can produce different cellular responses in mammalian cells that may be due to these compounds interacting with...
5.
Francisco K, Bruystens J, Varricchio C, McCurdy S, Wu J, Lopez-Ramirez M, et al.
ACS Pharmacol Transl Sci
. 2023 Nov;
6(11):1651-1658.
PMID: 37974623
The covalent reversible modification of proteins is a validated strategy for the development of probes and candidate therapeutics. However, the covalent reversible targeting of noncatalytic lysines is particularly challenging. Herein,...
6.
Zhao X, Zeng W, Xu H, Sun Z, Hu Y, Peng B, et al.
Sci Transl Med
. 2023 Sep;
15(713):eabo6889.
PMID: 37703352
Tau pathogenesis is a hallmark of many neurodegenerative diseases, including Alzheimer's disease (AD). Although the events leading to initial tau misfolding and subsequent tau spreading in patient brains are largely...
7.
Monti L, Liu L, Varricchio C, Lucero B, Alle T, Yang W, et al.
ChemMedChem
. 2023 Jul;
18(20):e202300193.
PMID: 37429821
Tubulin and microtubules (MTs) are potential protein targets to treat parasitic infections and our previous studies have shown that the triazolopyrimidine (TPD) class of MT-active compounds hold promise as antitrypanosomal...
8.
Alle T, Joyasawal S, Oukoloff K, Long K, Owyang Z, Francisco K, et al.
Bioorg Med Chem Lett
. 2023 Jun;
91:129363.
PMID: 37295616
Fluorinated alcohols and phenols are potentially useful as bioisosteres of the carboxylic acid functional group. To enable a direct comparison of the properties of fluorinated carboxylic acid surrogates with those...
9.
Lucero B, Francisco K, Liu L, Caffrey C, Ballatore C
Trends Pharmacol Sci
. 2023 Jun;
44(7):474-488.
PMID: 37263826
The development of small-molecule inhibitors or stabilizers of selected protein-protein interactions (PPIs) of interest holds considerable promise for the development of research tools as well as candidate therapeutics. In this...
10.
Monti L, Liu L, Varricchio C, Lucero B, Alle T, Yang W, et al.
bioRxiv
. 2023 Mar;
PMID: 36945407
Tubulin and microtubules (MTs) are potential protein targets to treat parasitic infections and our previous studies have shown that the triazolopyrimidine (TPD) class of MT- active compounds hold promise as...